Diabetes Secondary to Acromegaly: Physiopathology, Clinical Features and Effects of Treatment
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetes Secondary to Acromegaly: Physiopathology, Clinical Features and Effects of Treatment
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-07-06
DOI
10.3389/fendo.2018.00358
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Somatostatin Analogs and Glucose Metabolism in Acromegaly: A Meta-Analysis of Prospective Interventional Studies
- (2018) Alessia Cozzolino et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Novel Somatostatin Receptor Ligands Therapies for Acromegaly
- (2018) Rosa Maria Paragliola et al. Frontiers in Endocrinology
- MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects
- (2017) G Mazziotti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- High-Dose and High-Frequency Lanreotide Autogel in Acromegaly: A Randomized, Multicenter Study
- (2017) Andrea Giustina et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Controlled With Pegvisomant and First-Generation Somatostatin Analogues (PAPE Study)
- (2017) Ammar Muhammad et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A multicenter, observational study of lanreotide depot/autogel (LAN) in patients with acromegaly in the United States: 2-year experience from the SODA registry
- (2017) Roberto Salvatori et al. Pituitary
- Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities
- (2017) Rosario Pivonello et al. Pituitary
- The association between biochemical control and cardiovascular risk factors in acromegaly
- (2017) John D. Carmichael et al. BMC Endocrine Disorders
- Pegvisomant in acromegaly: an update
- (2017) A. Giustina et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Glucose and lipid levels with lanreotide autogel 120 mg in treatment-naïve patients with acromegaly: data from the PRIMARYS study
- (2016) Philippe J. Caron et al. CLINICAL ENDOCRINOLOGY
- What is the efficacy of switching to weekly pegvisomant in acromegaly patients well controlled on combination therapy?
- (2016) A Muhammad et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study
- (2016) Jakob Dal et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The Mexican Acromegaly Registry: Clinical and Biochemical Characteristics at Diagnosis and Therapeutic Outcomes
- (2016) Lesly A. Portocarrero-Ortiz et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Monotherapy with lanreotide depot for acromegaly: long-term clinical experience in a pituitary center
- (2016) Babak Torabi Sagvand et al. Pituitary
- Epidemiology of acromegaly: review of population studies
- (2016) Aikaterini Lavrentaki et al. Pituitary
- Metabolic syndrome and hypogonadism – two peas in a pod
- (2016) F Ebrahimi et al. SWISS MEDICAL WEEKLY
- Current and Emerging Aspects of Diabetes Mellitus in Acromegaly
- (2016) Stefano Frara et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study
- (2016) Marcello D. Bronstein et al. BMC Endocrine Disorders
- The prevalence of acromegaly in hospitalized patients with type 2 diabetes
- (2015) Kentaro Suda et al. ENDOCRINE JOURNAL
- Adverse events associated with somatostatin analogs in acromegaly
- (2015) Ludovica FS Grasso et al. Expert Opinion On Drug Safety
- Serum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations
- (2015) A. Ciresi et al. GROWTH HORMONE & IGF RESEARCH
- 60 YEARS OF NEUROENDOCRINOLOGY: Acromegaly
- (2015) Cristina Capatina et al. JOURNAL OF ENDOCRINOLOGY
- Safety of long-term treatment with Pegvisomant: analysis of Spanish patients included in global ACROSTUDY
- (2015) I. Bernabeu et al. Pituitary
- Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing’s syndrome and acromegaly
- (2015) M. G. Baroni et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Does pegvisomant treatment expertise improve control of resistant acromegaly? The Italian ACROSTUDY experience
- (2015) S. Cannavo et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- The Role of Diabetes in Acromegaly Associated Neoplasia
- (2015) Sonia Cheng et al. PLoS One
- Therapy of acromegalic patients exacerbated by concomitant type 2 diabetes requires higher pegvisomant doses to normalise IGF1 levels
- (2014) Michael Droste et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
- (2014) A. Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The impact of transsphenoidal surgery on glucose homeostasis and insulin resistance in acromegaly
- (2014) Maria Stelmachowska-Banaś et al. Neurologia i Neurochirurgia Polska
- Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
- (2014) Mônica R Gadelha et al. Lancet Diabetes & Endocrinology
- Prevalence of diabetes mellitus in patients with acromegaly
- (2014) A V Dreval et al. Endocrine Connections
- Management of hyperglycemia associated with pasireotide (SOM230): Healthy volunteer study
- (2013) Astrid Breitschaft et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effects of medical therapies for acromegaly on glucose metabolism
- (2013) C Urbani et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers
- (2013) Robert R. Henry et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Short-Term Administration of Pegvisomant Improves Hepatic Insulin Sensitivity and Reduces Soleus Muscle Intramyocellular Lipid Content in Young Adults With Type 1 Diabetes
- (2013) A. Thankamony et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial
- (2013) Philippe J. Caron et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients
- (2013) Orsalia Alexopoulou et al. Pituitary
- Metabolic Glucose Status and Pituitary Pathology Portend Therapeutic Outcomes in Acromegaly
- (2013) Sonia Cheng et al. PLoS One
- Predictors of morbidity and mortality in acromegaly: an Italian survey
- (2012) M Arosio et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis
- (2012) Roger Abs et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Long-term outcome in patients with acromegaly: analysis of 1344 patients from the German Acromegaly Register
- (2012) Christof Schöfl et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Visceral Adiposity Index Is Associated with Insulin Sensitivity and Adipocytokine Levels in Newly Diagnosed Acromegalic Patients
- (2012) A. Ciresi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effective Combination Treatment with Cabergoline and Low-Dose Pegvisomant in Active Acromegaly: A Prospective Clinical Trial
- (2012) C. E. Higham et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Metabolic Profile in Active Acromegaly is Gender-Specific
- (2012) A. Ciresi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Randomized pilot study of cabergoline, a dopamine receptor agonist: effects on body weight and glucose tolerance in obese adults
- (2011) C. D. Gibson et al. DIABETES OBESITY & METABOLISM
- Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic β-cell function is preserved
- (2011) Yuka Kinoshita et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy
- (2011) Gherardo Mazziotti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry
- (2011) Sandrine Fieffe et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Effects of somatostatin analogs on glucose homeostasis in rats
- (2011) Herbert A Schmid et al. JOURNAL OF ENDOCRINOLOGY
- Glucose status in patients with acromegaly receiving primary treatment with the somatostatin analog lanreotide
- (2011) Elisabeth Couture et al. Pituitary
- Clinical and metabolic effects of first-line treatment with somatostatin analogues or surgery in acromegaly: a retrospective and comparative study
- (2011) Carla Giordano et al. Pituitary
- Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL
- (2011) S. Cannavò et al. Pituitary
- Bromocriptine Mesylate for Glycemic Management in Type 2 Diabetes Mellitus
- (2010) Jessica L Kerr et al. ANNALS OF PHARMACOTHERAPY
- Increased prevalence of acromegaly in a highly polluted area
- (2010) S Cannavò et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Frequency of acromegaly in adults with diabetes or glucose intolerance and estimated prevalence in the general population
- (2010) Pedro Weslley Rosario Pituitary
- Clinical and biochemical characteristics of acromegalic patients with different abnormalities in glucose metabolism
- (2010) Ana Laura Espinosa-de-los-Monteros et al. Pituitary
- Age and sex as predictors of biochemical activity in acromegaly: analysis of 1485 patients from the German Acromegaly Register
- (2009) S. Petersenn et al. CLINICAL ENDOCRINOLOGY
- Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed
- (2009) Tirissa J. Reid et al. CLINICAL ENDOCRINOLOGY
- Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects
- (2009) Niels Møller et al. ENDOCRINE REVIEWS
- ACROSTUDY: the first 5 years
- (2009) Peter J Trainer EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Glucose Tolerance and Somatostatin Analog Treatment in Acromegaly: A 12-Month Study
- (2009) Annamaria Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pegvisomant Improves Insulin Sensitivity and Reduces Overnight Free Fatty Acid Concentrations in Patients with Acromegaly
- (2009) C. E. Higham et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies
- (2009) Gherardo Mazziotti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Lower Visceral and Subcutaneous but Higher Intermuscular Adipose Tissue Depots in Patients with Growth Hormone and Insulin-Like Growth Factor I Excess Due to Acromegaly
- (2008) Pamela U. Freda et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Function and expression of somatostatin receptors of the endocrine pancreas
- (2008) Mathias Z. Strowski et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started